Bendamustine-based conditioning for non-Hodgkin lymphoma autologous transplantation: an increasing risk of renal toxicity

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2016-02, Vol.51 (2), p.319-321
Hauptverfasser:	Garciaz, S, Coso, D, Schiano de Collela, J-M, Broussais, F, Stoppa, A-M, Aurran, T, Chabannon, C, Helvig, A, Xerri, L, Blaise, D, Bouabdallah, R
Format:	Artikel
Sprache:	eng
Schlagworte:	692/308 692/699 Adult Aged Autografts Bendamustine Bendamustine Hydrochloride - administration & dosage Bendamustine Hydrochloride - adverse effects Bone marrow Care and treatment Cell Biology Complications and side effects Dosage and administration Female Hematology Humans Internal Medicine Kidney Diseases - etiology Kidney failure letter-to-the-editor Lymphoma Lymphoma, Non-Hodgkin - therapy Male Medicine Medicine & Public Health Middle Aged Non-Hodgkin's lymphoma Non-Hodgkin's lymphomas Prognosis Public Health Risk factors Stem cell transplantation Stem Cell Transplantation - adverse effects Stem Cells Toxicity Transplantation Transplantation Conditioning - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!